Clinical Trials Sponsored by Pietro Impellizzeri

Total 852 results

Azienda Ospedaliera Universitaria Policlinico "G...
Eloisa Gitto; Lucia Marseglia; Gabriella D'Angelo; Sara Manti; Simona Montalto; Pietro...

Completed

Melatonin Premedication in Children Undergoing Surgery

Anaesthesia | Premedication
Hospital San Pietro Fatebenefratelli

Completed

Crestal vs Lateral Sinus Lift Augmentation

Edentulous Alveolar Ridge | Bone Atrophy, Alveolar

Albania
Pietro Iaffaldano

Completed

Cognitive Impairment in Pediatric Onset Multiple Sclerosis

ADHD Predominantly Inattentive Type | Pediatric Onset Multiple Sclerosis
Pedro-José Torrijos-Garrido

Recruiting

Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomized Clinical Trial

Tibial Plateau Fracture

Spain
Pedro-José Torrijos-Garrido

Recruiting

Effect Of The Use Of Navigation In The Alignment Obtained When Performing A Total Knee Arthroplasty In Obese Patients

Obesity | Osteoarthritis, Knee | Arthropathy of Knee

Spain
Hospital San Pietro Fatebenefratelli
Nobel Biocare

Withdrawn

Splint Versus Non-splint Implant Impressions

Dental Implants | Dental Impression Materials | Dental Impression Techniques

Italy
Pietro Mortini, MD, Prof.

Recruiting

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Brain Tumor, Primary | Brain Tumor - Metastatic

Italy
Pierre Fabre Medicament
Pierre Fabre Pharma GmbH

Completed

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NSCLC

Germany
Pierre Fabre Medical Devices

Completed

Xerotic Dermatitis in Aged People

Itching Symptoms | Xerotic Dermatitis

France
Pierre Fabre Pharma GmbH
Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (BERING)

Melanoma Stage IV | Melanoma Stage III

Austria, Germany, Switzerland
Clayton Petro

Recruiting

The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

Hernia, Ventral | Ileus

United States
Clayton Petro

Recruiting

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

Postoperative Pain | Inguinal Hernia

United States
Clayton Petro

Completed

Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair

Hiatal Hernia Large | Paraesophageal Hernia

United States
Clayton Petro

Recruiting

Suture Repair vs Mesh Repair for Incisional Hernia

Incisional Hernia

United States
Clayton Petro

Completed

Parastomal Hernia Repair Utilizing the Retromuscular Sugarbaker Versus Keyhole Mesh Techniques

Parastomal Hernia

United States
Hospital San Pietro Fatebenefratelli
Geistlich Pharma AG; Nobel Biocare

Withdrawn

Study on Immediate Loading of Immediately Placed Single Implants.

Dental Implants

Italy
Pierre Fabre Medicament

Recruiting

A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients (TavieSkin)

Metastatic Melanoma | Melanoma (Skin) | BRAF V600 Mutation

Portugal
Pierre Fabre Medicament

Active, not recruiting

A Study of a New Investigational Medicinal Product to Treat Patients With Advanced or Metastatic Solid Tumors (Ulysse)

Advanced or Metastatic Solid Tumors

France, Spain
Pierre Fabre Medicament

Completed

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Breast Cancer | Metastases

France, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
Pierre Fabre Medicament

Completed

Efficacy and Safety Study of F373280

Atrial Fibrillation

Spain, Hungary, Italy, Poland, Czechia
Pierre Fabre Medicament

Completed

Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

Breast Cancer
Pierre Fabre Medicament

Completed

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study

Recurrent Upper-Respiratory Tract Infections

Italy, Poland, Romania, Russian Federation, Lithuania
Pierre Fabre Medicament

Terminated

Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia

Iron Deficiency Anemia

Bulgaria, Romania
Pierre Fabre Medicament

Completed

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin (JASINT1)

Bladder Transitional Cell Carcinoma Stage IV

France
Pierre Fabre Medicament

Completed

Assessment of V0018 2.5 mg Effect on Craving

Healthy Highly Dependant Smokers

France
Pierre Fabre Medicament

Completed

Effect of F2695 on Functional Recovery After Ischemic Stroke (LIFE)

Ischemic Stroke

Spain, France, Switzerland, Germany, Sweden, Italy, Czech Republic, Portugal, Belgium, Hungary, Russian Federation
Pierre Fabre Dermatology

Completed

Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo

Infantile Hemangioma

Spain, France, Poland
Pierre Fabre Medicament

Completed

Effect of V0251 in Acute Vertigo

Acute Vertigo

Spain, France, Germany, Czech Republic, Hungary
Pierre Fabre Medicament

Completed

Ibuprofen Lozenge in Acute Sore Throat Pain

Acute Sore Throat Pain

United Kingdom, Germany, Latvia, France
Pierre Fabre Dermatology

Completed

Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects

Healthy Volunteers

Germany
Pierre Fabre Medicament

Completed

Nicotine Patch Bioequivalence Study

Healthy Smokers

France
Pierre Fabre Medicament

Completed

Nicotine Patch - Multidose Bioequivalence Study

Healthy Smokers

France
Pierre Fabre Medicament

Completed

Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations

Healthy Smokers

France
Hospital Pedro Hispano
Diogo Melo Pinto, MD, Hospital Pedro Hispano; Telma Fonseca, MD, Centro Hospitalar... and other collaborators

Completed

Evaluation of cfDNA as a Marker of Response in Rectal Cancer

Cancer of Rectum

Portugal
Pierre Fabre Medicament

Not yet recruiting

Treatment Patterns of Neratinib in HER2+ EBC in China

Breast Cancer

China
Pierre Fabre Medicament

Terminated

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

France, Spain
Pierre Fabre Medicament

Active, not recruiting

Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer (OCEANII)

Non-Small Cell Lung Cancer

China, Taiwan
Pierre Fabre Medicament

Completed

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Breast Cancer

France, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
Pierre Fabre Medicament

Completed

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Malignant Neoplasm of Breast

China, Taiwan, Singapore
Pierre Fabre Medicament

Completed

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Recurrent or Metastatic Head and Neck Carcinoma

France
Pierre Fabre Dermatology

Withdrawn

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Healthy Volunteers

United Kingdom
Pierre Fabre Dermatology

Completed

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Infantile Hemangioma

Germany, United States, France, Spain, Peru, Australia, Lithuania, Italy, Canada, Czech Republic, Hungary, Mexico, New Zealand, Poland, Romania, Russian Federation
Bistro Study Group

Completed

Quality of Chest Compressions After a Night Shift (WeCAN)

Cardiac Arrest

France
Pierre Fabre Medicament

Completed

Nicotine Patch - Bioequivalence Study

Healthy Smokers

France
Pierre Fabre Medicament

Completed

Emollients in the Management of Atopic Dermatitis

Atopic Dermatitis

France, Romania, Estonia, Poland, Lithuania
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
Pierre Fabre Medicament

Completed

FMS European Long-Term Study

Fibromyalgia Syndrome

Spain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden
Pierre Fabre Medicament

Completed

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

Atopic Dermatitis

Estonia, France, Lithuania, Poland, Romania
Pierre Fabre Medicament

Withdrawn

Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Hepatic Impairment | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

Spain, Czechia, Italy
Pierre Fabre Medicament

Completed

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors (OCEANI)

Melanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLC

China

Clinical Trials Sponsored by Pietro Impellizzeri

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations